Comments

Abeona Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Abeona Therapeutics (ABEO) operate in?

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ABEONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Abeona Therapeutics (ABEO) Forecast

News Earnings Abeona Therapeutics (ABEO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Abeona Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ABEO | Benzinga

Explore Abeona Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABEO.

Open	$6.10
Close	-
Volume / Avg.	130.15K / 1.59M
Day Range	$5.98 - $6.11
52 Wk Range	3.93 - 7.32
Market Cap	$309.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	12.33%
Days to Cover	2.81

Recent News

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease

Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.10
Close	-
Volume / Avg.	130.15K / 1.59M
Day Range	$5.98 - $6.11
52 Wk Range	3.93 - 7.32
Market Cap	$309.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	12.33%
Days to Cover	2.81

About Abeona Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Abeona Therapeutics (ABEO) stock?

You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.

View our list of the best stock brokerages

Who are Abeona Therapeutics (ABEO) competitors?

Other companies in Abeona Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Inozyme Pharma (NASDAQ:INZY), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and Tonix Pharmaceuticals (NASDAQ:TNXP).

What is the forecast, or price target, for Abeona Therapeutics (ABEO) stock?

Abeona Therapeutics has a consensus price target of $16.43.

What is the current price for Abeona Therapeutics (ABEO)?

The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $6.058 last updated May 28, 2025 at 10:19 AM EDT.

Does Abeona Therapeutics (ABEO) pay a dividend?

There are no upcoming dividends for Abeona Therapeutics.

When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?

Abeona Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Abeona Therapeutics (ABEO) going to split?

There is no upcoming split for Abeona Therapeutics.

What sector and industry does Abeona Therapeutics (ABEO) operate in?

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.